Trial intelligence / Profile preview

Goserelin for Ovarian Function Preservation in Breast Cancer

NCT02483767Phase 3Completed

Sponsor
Peking Union Medical College Hospital
Start
Jun 2015
Primary completion
Nov 2016
Modality
Peptides, Small Molecules
01

Overview

A Phase 3 trial of goserelin in primary ovarian insufficiency (POI), sponsored by Peking Union Medical College Hospital. Started Jun 2015; status: completed.

02

Drugs

goserelin
03

Conditions

primary ovarian insufficiency (POI)

Beyond the preview

Go deeper on NCT02483767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02483767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call